There’s a better way to scale AI.

Amir Dan Rubin is the CEO & Founding Managing Partner of Healthier Capital, a venture capital firm backing early and growth-stage companies that leverage technology and new business models to improve health outcomes and experiences. Previously, Amir served as CEO of One Medical | Amazon, where he expanded the member-based primary care organization to 31 markets nationwide, advanced its technology platform, grew its consumer and enterprise reach, and launched services for seniors in Medicare Advantage. Under his leadership, One Medical completed a $350 million private financing, a $1.7 billion IPO in 2020, and a $3.9 billion acquisition by Amazon,at the time Amazon’s third-largest acquisition. Before One Medical, Amir was an Executive Vice President at UnitedHealth Group’s Optum division, leading a $30 billion portfolio spanning care delivery, behavioral health, and specialty networks. He earlier served as President & CEO at Stanford Health Care, where he elevated patient experience and quality scores to national best-in-class levels, quadrupled income, expanded the system’s regional network, and helped pioneer one of the first video-visit programs on an EHR platform. Amir also held executive roles as COO at UCLA Health,whose transformation was chronicled in Prescription for Excellence,and COO at Stony Brook University Hospital, with earlier leadership at Memorial Hermann Health System and APM/CSC. He has twice been named EY Entrepreneur of the Year (Northern California), recognized among Modern Healthcare’s Most Powerful Leaders, and honored as a Top Business Leader in San Francisco. Amir holds MBA and MHSA degrees from the University of Michigan and a BA from the University of California, Berkeley.

Frank Williams is co-founder and board director of Evolent Health (NYSE: EVH), a company that assists payers and providers in improving health outcomes through value-based care transformation. During his tenure, the company completed an IPO, grew to $1B+ in annualized revenue and served over 15MM+ patients. Evolent was also named to Forbes list of America’s most promising companies, as well as a top 3 Employer in the United States. In addition, Frank was selected as the top CEO nationwide by Glassdoor. Prior to Evolent, Frank served as chairman and CEO of The Advisory Board Company (NASDAQ: ABCO), a global research and technology firm that served over 5,000 organizations across the health care sector. During Frank's tenure as both its chairman and CEO, The Advisory Board completed an initial public offering and grew to $450M+ in annual revenues with over 2,500 employees and $2B+ in market capitalization. Along with Evolent Health, Frank currently serves on the boards of Helix, Nayya, Syapse, Trusted Health and Wellth. He also serves as a senior advisor to ICER, Blackbird and the President's Advisory Council for the School of Public Health at Brown University. A native Californian, Frank received a BA in Political Economies of Industrial Societies from the University of California, Berkeley, and an MBA from Harvard Business School.

Andy Slavitt was President Biden’s White House Senior Advisor for the Covid response. He is currently a member of a President’s Council of Advisors on Science and Technology (PCAST) working group on public health. He has led many of the nation’s most important health care initiatives, serving as President Obama’s head of Medicare and Medicaid and overseeing the turnaround, implementation and defense of the Affordable Care Act. Slavitt is the “outsider’s insider”, serving in leading private and non-profit roles in addition to his government services. He is founder and Board Chair Emeritus of United States of Care, a national non-profit health advocacy organization as well as a founding partner of Town Hall Ventures, a healthcare firm that invests in underrepresented communities. He co-chaired a national initiative on the future of health care at the Bipartisan Policy Center. He chronicles what goes on inside the government and across the nation at town halls, in USA Today, on his award-winning podcast In the Bubble, and on Twitter. He is the author of Preventable, a best-selling account of the US’s Coronavirus response released in 2021. A graduate of the University of Pennsylvania and Harvard Business School, he and his wife have two grown sons.

DJ Patil is an entrepreneur, investor, scientist, and leader in public policy. He has held senior roles in industry, academia, and government and his work has been featured in two Michael Lewis books (The Fifth Risk and Premonition). As a General Partner at GreatPoint Ventures he focuses on building companies in healthcare, enterprise technologies, and national security. He is a board member for Devoted Health where he was an executive on the founding team and CTO with the mission to build a health care system that takes care of every member like they were family. Previously he led the product teams at RelateIQ which was acquired by Salesforce, and was founding board member for Crisis Text Line which works to use new technologies to provide on demand mental health and crisis support. At LinkedIn he was Chief Scientist, Chief Security Officer and also held a number of roles at Skype, PayPal, and eBay. DJ's public policy work includes being appointed by President Obama to be the first U.S. Chief Data Scientist where his efforts led to the establishment of nearly 40 Chief Data Officer roles across the Federal government. Establishing new health care programs including the Precision Medicine Initiative (now the NIH All of Us program) and the Cancer Moonshot, new criminal justice reforms including the Data-Driven Justice and Police Data Initiatives that cover more than 94 million Americans, as well as leading the national data efforts.

Mohamad Makhzoumi is Co-CEO and Managing General Partner of New Enterprise Associates (NEA), one of the world’s largest venture capital firms with more than $25 billion in committed capital. Over more than two decades at NEA, he has helped build the firm into one of the most influential investors in healthcare technology and services. Makhzoumi joined NEA in 2000 and rose through the organization over the next two decades, ultimately becoming Managing General Partner of Healthcare, where he led NEA’s global healthcare investing practice across digital health, healthcare services, and life sciences. He later served as Co-President of NEA before being named Co-CEO, where he now oversees the firm’s global investment strategy and operations. Across his investing career, Makhzoumi has backed and served on the boards of numerous influential healthcare companies. His board and investment portfolio has included companies such as Radiology Partners, Collective Health, Everside Health, Strive Health, Nuvolo, AllyAlign Health, Waymark, Vori Health, PayZen, Belong Health, Aetion, and NeueHealth, among others. Earlier in his career, he worked in growth equity investing at Summit Partners and began his career as an investment banker at UBS Investment Bank. Makhzoumi received his bachelor’s degree with distinction from the University of Pennsylvania. He also serves on the boards of several nonprofit and industry organizations, including the National Venture Capital Association and the Lucile Packard Foundation for Children’s Health at Stanford.

Jarred Kesselheim is a Managing Partner at Transformation Capital, a healthcare growth equity firm focused on technology companies transforming clinical care delivery, healthcare operations, and life sciences. He brings more than two decades of experience spanning clinical medicine, venture capital, and digital health innovation. Dr. Kesselheim co-founded the predecessor to Transformation Capital alongside Todd Cozzens and other partners and has helped lead investments across multiple funds into companies building the infrastructure of modern healthcare. His investment work has included companies such as Vera Whole Health, CapitalRx, CareRev, Thriveworks, LightForce Orthodontics, Jeenie, Aktana, Protenus, Groups Recover Together, Panalgo, and Nira Medical, among others. Earlier in his career, Dr. Kesselheim was a Partner at Bain Capital Ventures, where he helped build the firm’s digital health investment practice. During that time he was involved in investments in several prominent healthcare technology companies including Apixio, Remedy Partners, ABILITY Network, MedHOK, National Cardiovascular Partners, and Liazon, many of which later achieved successful acquisitions or public market exits. Before entering venture capital, he trained and practiced as a physician after completing his residency at Massachusetts General Hospital, where his firsthand exposure to the limitations of legacy healthcare technology sparked his interest in investing in companies modernizing the healthcare system. Dr. Kesselheim holds a B.A. from Harvard College, an M.D. from Harvard Medical School, and an M.B.A. from Harvard Business School.

Eric is a national healthcare strategist, author, and advisor to CEOs and boards of global healthcare companies. For 25 years at The Advisory Board Company (including five years as President and now President Emeritus), he led the development of best practices to improve U.S. and global healthcare. After the company’s acquisition by Optum (UnitedHealth Group) in 2017, he co-led health system partnerships at Optum and shaped market strategy at UnitedHealth. Eric is active in healthcare venture capital,serving as Venture Partner at Thrive Capital and SignalFire,and sits on the boards of R1 RCM, Fuze Health and Thrive Global (supporting Arianna Huffington). He’s also served on boards in digital health and AI-powered care, including companies focused on kidney value-care and hospital-at-home innovation. Beyond healthcare, Eric chairs the board of Washington National Opera and is a trustee of The Washington Ballet. A graduate of Georgetown University’s School of Foreign Service (1995), he and his wife Susi live in Washington D.C. and San Francisco with their three teenage children, and have traveled to 100 countries across all seven continents.

Dr. Lungren is Chief Scientific Officer at Microsoft Health & Life Sciences, where he leads the integration of generative AI and cloud technologies into healthcare. A physician and clinical machine learning researcher, he also serves as an adjunct professor at Stanford University. Previously, he led Stanford’s Center for AI in Medicine and Imaging and held a clinical AI leadership role at Amazon Web Services. Author of over 200 publications, Dr. Lungren advises startups and global companies on healthcare AI strategy. His work has been widely featured in national media, and he teaches top-rated AI in healthcare courses for non-technical audiences.

Patrick Conway, M.D., M.Sc., is the CEO of Optum, part of UnitedHealth Group. He leads a portfolio of care continuum businesses with over $30 billion in annual revenue serving over 50 million people across acute and post-acute care, care in the home in-person and virtually, mental and behavioral care benefits and delivery, broad population and complex disease health management, specialty care, and government health services. From 2017-2019, he was President and CEO of Blue Cross and Blue Shield of North Carolina leading the organization to be recognized nationally for innovation, value-based payment, and investments in better health outcomes. From 2011-17, Conway served as Deputy Administrator for Innovation and Quality at the federal Centers for Medicare and Medicaid Services (CMS) and as Director of the Center for Medicare and Medicaid Innovation (CMMI) and the agency’s Chief Medical Officer. He also served as Principal Deputy Administrator and Acting Administrator of CMS. Before joining CMS, he over-saw clinical operations and quality improvement at Cincinnati Children’s Hospital Medical Center. He remains a practicing pediatric hospitalist. A respected leader, innovator and clinician, he was elected to the National Academy of Medicine (NAM) in 2014, received the President’s Senior Executive Distinguished Service award, and was a White House Fellow in 2007-08. Dr. Conway received his M.D. with High Honors from Baylor College of Medicine, residency training at Boston Children’s Hospital, and Master’s of Science in Clinical Epidemiology from the University of Pennsylvania.

Bill builds and transforms software companies across scale, stage, and sector. Over the past three decades, he has led and contributed to products and businesses used by billions of people and millions of companies. His experience spans nearly every function and level,from engineering and product to go-to-market, and from frontline operator to President, CEO, Co-Founder, and Board Chair. Bill has worked inside Fortune 10 enterprises as well as early-stage startups, navigating waves of technological and organizational change. He has founded ventures, scaled high-growth companies, and led complex turnarounds. What drives him is working with passionate teams on ambitious quests, aligning product, go-to-market, and people systems to unlock growth, build markets, and help organizations and individuals know more, do more, and be more.

Simon leads the US investment efforts at Cathay Innovation, a global venture capital firm managing over $2.5B AUM. He focuses on Series A/B rounds of software, fintech, digital healthcare, and consumer investments based in the US, and has led and/or supported early stage investments in companies including Chime, ZenBusiness (board), Ghost (board), Sidecar (board), Skan (board), Range (board), and Trifacta (acq by Alteryx), among others. Prior to joining Cathay Innovation, Simon spent 4 years at VMware on the Strategy & Corporate Development team which was responsible for leading acquisitions, investments, and strategy. As a Manager, he was involved in numerous transactions focusing on enterprise software sectors such as cloud computing, cybersecurity and mobile/end-user computing. Before joining VMware, he spent time at UBS in the investment banking division as part of the Technology, Media, and Telecommunications group. While at UBS, Simon advised on capital raises, corporate strategy and mergers & acquisitions for companies in the technology sector. Simon holds both a B.S. in Business Administration from the Haas School of Business and a B.A. in Operations Research and Management Science from the University of California Berkeley.

Ian is a Partner at Flare Capital Partners, where he led investments in Isaac Health, Knownwell, Peer AI, and Rx Redefined, and was a core team member on investments including Cayaba Care, Inbound Health, Oshi Health, and RightMove (where he serves on the board). He also led several Flare Scholar Ventures investments, including EarlyBird Education (acquired by Imagine Learning) and Vincere Health (acquired by RVO Health). Previously, Ian was a founding executive at CareAllies, Cigna’s multi-payer provider services and population health platform, helping build and scale the business prior to its $3.3B sale to Health Care Service Corporation in 2025. Earlier in his career, he co-founded XcelDx, which became Scanwell Health (acquired by Becton, Dickinson and Company), and began his career advising healthcare clients at McKinsey & Company. He holds a BS in Biological Engineering from Cornell University and an MBA from Harvard Business School.

Sooah joined SignalFire in 2023 as a Partner focused on investments in early-stage health and life sciences tech. Prior to SignalFire, she was a product leader at CVS Health, where she launched nationwide prescription delivery and virtual care products, and Devoted Health, currently valued at over $12 billion.

At Underscore VC, she invested in fast-growing B2B software startups, including life sciences tech products used by leading biopharma companies across the drug development cycle from R&D to commercial stages. She began her career at Michael Porter’s strategy firm where she advised healthcare & biopharma executives.

Sooah has a joint-degree MBA | MPP from Harvard Business School and Harvard Kennedy School, where she worked with startup founders at the HBS Rock Center for Entrepreneurship and built her digital health investment thesis as a Rock Venture Partner with Bain Capital.

As a product builder, GTM strategist, and policy nerd turned investor, she partners with founders at the earliest stages of their discovery, building, and scaling journey. She’s excited to reimagine how we develop, deliver, & pay for healthcare today and usher in a new era of AI-enabled health and longevity for all.

‍

Meera is a physician and General Partner at Town Hall Ventures. She was previously a Senior Partner in McKinsey & Company’s healthcare practice and leader of their Medicaid practice. Meera brings over a decade of experience across the healthcare value chain, including with regional and national health insurers, health systems, State and local health and human services agencies, pharmacy benefit managers, and institutional investors. Meera brings a longstanding commitment to health equity, especially for underserved communities. In launching and scaling up the Medicaid practice nationally, Meera has established herself as one of the national leaders focused on the programs that serve vulnerable Americans. She is a trusted partner to public and private sector institutions across strategy, product development, commercial contracting, and value-based care transformation. Meera has been a featured speaker or panelist at numerous industry events, including the Blue Cross Blue Shield Association National Summit, the National Governors Association, and Medicaid Health Plans of America.

‍

Navid is a Managing Partner with Frist Cressey Ventures. Before joining FCV in 2019, he served as a partner with Morgan Noble Healthcare Partners, a Washington, D.C. based firm investing in companies determined to transform the delivery of healthcare.  Prior to Morgan Noble, he was with Enhanced Healthcare Partners, a healthcare-focused private equity firm based in New York, as well as Lehman Brothers in the health care investment banking division, Ernst & Young’s Transaction Advisory group and Arthur Andersen’s health care practice.

Currently, Navid serves as a director or observer on the boards of the Nashville Health Care Council, Bicycle Health, Carta Healthcare, Dexcare, Lynx, Memora Health, Oshi Health, Psych Hub, RightMove, Spectrum AI, Thrive Mobile, Vim and Visana.  He also serves on the advisory board of The Hilltop Institute, a research and data analytics organization dedicated to improving the health and wellbeing of communities. In recognition for his exceptional work in pushing innovation toward better healthcare for all, Navid was named as a 2022 Top 50 in Digital Health honoree by Rock Health.

Navid holds an MBA from the NYU Stern School of Business and a BA from Loyola University in Maryland.

‍